Skip to main content

Table 11 Number of genes in the KEGG DA Pathway, KEGG PD Pathway, and both KEGG DA and PD Pathways in the respective prioritized gene sets

From: Efficient and biologically relevant consensus strategy for Parkinson’s disease gene prioritization

Prioritization

Approach

N

n(%)

%

DA

PD

DA-PD

DA-PD/DA

ML Limma

246

11(4.47)

6(2.44)

4(1.63)

36.36

ML

168

7(4.17)

5(2.98)

4(2.38)

57.14

Limma

134

9(6.72)

6(4.48)

4(2.99)

44.44

ML ∩ Limma

56

5(8.93)

5(8.93)

4(7.14)

80.00

Only-ML

112

2(1.79)

0(0.00)

0(0.00)

0.00

Only-Limma

78

4(5.13)

1(1.28)

0(0.00)

0.00

Consensus

50

5(10.00)

5(10.00)

4(8.00)

80.00

  1. N: Number of genes prioritized; n: number; %: percentage; DA: genes in the KEGG Dopaminergic Synapse Pathway; PD: genes in the KEGG Parkinson’s Disease Pathway; DA-PD: genes in the KEGG Dopaminergic Synapse Pathway and the KEGG Parkinson’s Disease Pathway